| Literature DB >> 26775900 |
Lauren Narcross1, Elena Fossati1, Leanne Bourgeois1, John E Dueber2, Vincent J J Martin3.
Abstract
Benzylisoquinoline alkaloids (BIAs) are a family of ∼2500 alkaloids with both potential and realized pharmaceutical value, including most notably the opiates such as codeine and morphine. Only a few BIAs accumulate readily in plants, which limits the pharmaceutical potential of the family. Shifting BIA production to microbial sources could provide a scalable and flexible source of these compounds in the future. This review details the current status of microbial BIA synthesis and derivatization, including rapid developments in the past 6 months culminating in the synthesis of opioids from glucose in a microbial host.Entities:
Keywords: aromatic amino acids; benzylisoquinoline alkaloids; biosecurity; dopamine; microbial synthesis; morphinans
Mesh:
Substances:
Year: 2016 PMID: 26775900 DOI: 10.1016/j.tibtech.2015.12.005
Source DB: PubMed Journal: Trends Biotechnol ISSN: 0167-7799 Impact factor: 19.536